Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab
======================================================================================================================================================================================================

* Philip Friedlander
* Karl Wassmann
* Alan M. Christenfeld
* David Fisher
* Chrisann Kyi
* John M. Kirkwood
* Nina Bhardwaj
* William K. Oh